E-resources
PDF-
Collins, Sean P., MD, MSc; Levy, Phillip D., MD, MPH; Martindale, Jennifer L., MD; Dunlap, Mark E., MD; Storrow, Alan B., MD; Pang, Peter S., MD, MSc; Albert, Nancy M., RN, PhD; Felker, G. Michael, MD, MS; Fermann, Gregory J., MD; Fonarow, Gregg C., MD; Givertz, Michael M., MD; Hollander, Judd E., MD; Lanfear, David J., MD; Lenihan, Daniel J., MD; Lindenfeld, JoAnn M., MD; Peacock, W. Frank, MD; Sawyer, Douglas B., MD, PhD; Teerlink, John R., MD; Butler, Javed, MD, MPH, MBA
Journal of cardiac failure, 08/2016, Volume: 22, Issue: 8Journal Article
Abstract Management approaches for patients in the emergency department (ED) who present with acute heart failure (AHF) have largely focused on intravenous diuretics. Yet, the primary pathophysiologic derangement underlying AHF in many patients is not solely volume overload. Patients with hypertensive AHF (H-AHF) represent a clinical phenotype with distinct pathophysiologic mechanisms that result in elevated ventricular filling pressures. To optimize treatment response and minimize adverse events in this subgroup, we propose that clinical management be tailored to a conceptual model of disease based on these mechanisms. This consensus statement reviews the relevant pathophysiology, clinical characteristics, approach to therapy, and considerations for clinical trials in ED patients with H-AHF.
